The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA3914036
PubChem CID: 134143033
Max Phase: Preclinical
Molecular Formula: C24H24F3N7O3S
Molecular Weight: 547.56
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CS(=O)(=O)N1CCCC(=O)N2CCc3cc(ccc32)Nc2ncc(C(F)(F)F)c(n2)NCc2cccnc21
Standard InChI: InChI=1S/C24H24F3N7O3S/c1-38(36,37)34-10-3-5-20(35)33-11-8-15-12-17(6-7-19(15)33)31-23-30-14-18(24(25,26)27)21(32-23)29-13-16-4-2-9-28-22(16)34/h2,4,6-7,9,12,14H,3,5,8,10-11,13H2,1H3,(H2,29,30,31,32)
Standard InChI Key: VAISRJZBJKFESC-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
4.2676 -12.4353 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6803 -13.1452 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.0887 -12.4329 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2673 -9.8847 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2662 -10.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9742 -11.1132 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6839 -10.7037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6811 -9.8811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9725 -9.4758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3845 -9.4699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0271 -9.0957 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.1839 -9.7704 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.5176 -8.6263 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.3923 -11.1112 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3935 -11.9284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1019 -12.3359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0986 -13.1504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8061 -13.5578 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5141 -13.1481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5102 -12.3267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8021 -11.9230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5582 -11.1122 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5676 -11.9293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8645 -12.3445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2918 -13.1410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2792 -12.3260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5865 -13.5621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8715 -13.1635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2713 -13.7203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6155 -14.4632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4283 -14.3654 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3902 -13.5579 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3860 -14.3751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6763 -14.7802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9706 -14.3680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9747 -13.5557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1326 -14.7714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1331 -15.5885 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 1 0
10 12 1 0
10 13 1 0
8 10 1 0
7 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
17 32 1 0
5 22 1 0
22 23 1 0
23 24 2 0
24 28 1 0
27 25 1 0
25 26 2 0
26 23 1 0
27 28 2 0
28 29 1 0
29 30 1 0
30 31 1 0
31 27 1 0
32 2 1 0
32 33 1 0
33 34 1 0
34 35 1 0
2 36 1 0
31 37 1 0
37 38 2 0
37 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 547.56Molecular Weight (Monoisotopic): 547.1613AlogP: 3.70#Rotatable Bonds: 1Polar Surface Area: 120.42Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.30CX Basic pKa: 4.26CX LogP: 2.18CX LogD: 2.18Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.47Np Likeness Score: -1.07
References 1. Farand J, Mai N, Chandrasekhar J, Newby ZE, Van Veldhuizen J, Loyer-Drew J, Venkataramani C, Guerrero J, Kwok A, Li N, Zherebina Y, Wilbert S, Zablocki J, Phillips G, Watkins WJ, Mourey R, Notte GT.. (2016) Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potency., 26 (24): [PMID:27876318 ] [10.1016/j.bmcl.2016.10.092 ]